Capsida

Developer of next-generation AAV platform for gene therapies

placeNewbury Park, California, United States calendar_todayFounded 2019 groups134 employees language capsida.com

Registered entities

Social engagement

Social engagement: 17.1K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

3 investors on record; lead investors include Westlake Village Biopartners, Versant Ventures.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%

Recent activity

3 Sep 2025
Event
Carlos Stanley 23rd Annual Global Healthcare Conference
7 Aug 2025
Product launch
CAP-004
24 Jul 2025
Event
2025 Syntaxin-binding protein 1 (STXBP1) Summit+ Family Meeting
Coming soon